Trial Outcomes & Findings for Adductor Canal Catheter Effectiveness and Safety Study (NCT NCT04639128)
NCT ID: NCT04639128
Last Updated: 2024-04-25
Results Overview
Ordinal 0-to-10 point scale of pain severity Minimum value: 0 Maximum value: 10 Higher scores mean more pain
COMPLETED
NA
126 participants
Second postoperative day
2024-04-25
Participant Flow
Participant milestones
| Measure |
No-Device
No placement of an adductor canal catheter
|
Device
Placement of an adductor canal catheter
Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
|
|---|---|---|
|
Overall Study
STARTED
|
63
|
63
|
|
Overall Study
COMPLETED
|
60
|
62
|
|
Overall Study
NOT COMPLETED
|
3
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Adductor Canal Catheter Effectiveness and Safety Study
Baseline characteristics by cohort
| Measure |
No-Device
n=63 Participants
No placement of an adductor canal catheter
|
Device
n=63 Participants
Placement of an adductor canal catheter
Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
|
Total
n=126 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
66.3 years
STANDARD_DEVIATION 8.6 • n=5 Participants
|
66.5 years
STANDARD_DEVIATION 9.3 • n=7 Participants
|
66.5 years
STANDARD_DEVIATION 8.9 • n=5 Participants
|
|
Sex: Female, Male
Female
|
36 Participants
n=5 Participants
|
35 Participants
n=7 Participants
|
71 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
27 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
55 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
7 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
6 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
44 Participants
n=5 Participants
|
37 Participants
n=7 Participants
|
81 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
6 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
63 participants
n=5 Participants
|
63 participants
n=7 Participants
|
126 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Second postoperative dayPopulation: Had surgery and able to provide postoperative day-2 pain score
Ordinal 0-to-10 point scale of pain severity Minimum value: 0 Maximum value: 10 Higher scores mean more pain
Outcome measures
| Measure |
No-Device
n=60 Participants
No placement of an adductor canal catheter
|
Device
n=62 Participants
Placement of an adductor canal catheter
Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
|
|---|---|---|
|
Pain Numerical Rating Scale
|
6.38 score on a scale
Standard Error 0.30
|
5.31 score on a scale
Standard Error 0.32
|
SECONDARY outcome
Timeframe: 15 postoperative daysPopulation: Numbers of participants do not equal those of the pain-score analyses due to missing data
Total number of 5mg oxycodone tablets (provided to all patients on discharge) consumed over the 15-day postoperative period as recorded in the daily pain-and-medication postoperative diary
Outcome measures
| Measure |
No-Device
n=47 Participants
No placement of an adductor canal catheter
|
Device
n=46 Participants
Placement of an adductor canal catheter
Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
|
|---|---|---|
|
Opioid Consumption in the 15-day Postoperative Period
|
41.9 5mg oxycodone tablets
Standard Error 4.20
|
46.0 5mg oxycodone tablets
Standard Error 5.59
|
Adverse Events
No-Device
Device
Serious adverse events
| Measure |
No-Device
n=63 participants at risk
No placement of an adductor canal catheter
|
Device
n=63 participants at risk
Placement of an adductor canal catheter
Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
|
|---|---|---|
|
Nervous system disorders
Vertigo
|
0.00%
0/63 • 30 days postoperatively
|
1.6%
1/63 • Number of events 1 • 30 days postoperatively
|
|
Gastrointestinal disorders
Small-bowel obstruction
|
1.6%
1/63 • Number of events 1 • 30 days postoperatively
|
0.00%
0/63 • 30 days postoperatively
|
|
Cardiac disorders
Atrial fibrillation
|
1.6%
1/63 • Number of events 1 • 30 days postoperatively
|
0.00%
0/63 • 30 days postoperatively
|
|
Skin and subcutaneous tissue disorders
Wound dehiscence
|
1.6%
1/63 • Number of events 1 • 30 days postoperatively
|
0.00%
0/63 • 30 days postoperatively
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place